Legal

Terms of Use

These terms govern access to the invite-only ScalpelNote professional pilot operated by CoMo Labs Limited.

Last updated: 10 July 2026

1. Operator and acceptance

ScalpelNote is operated by CoMo Labs Limited, Incubator Building, Masdar City, Abu Dhabi, United Arab Emirates, Licence No. MC 14674. By requesting access or using the service, you agree to these terms. If you use ScalpelNote for an organisation, you confirm that you are authorised to do so and must also follow its policies.

2. Professional private pilot

Access is limited to invited adult healthcare professionals and authorised reviewers. The pilot is provided to test workflow and template quality. Availability and features may change, and we may limit, suspend, or end pilot access with reasonable notice where practical.

3. Documentation assistant, not medical advice

  • ScalpelNote produces draft documentation for physician review.
  • It does not diagnose, select treatment, determine medication or dose, assign billing codes autonomously, or replace clinical judgment.
  • You must verify every fact, assumption, omission, conflict, and required field before using a report.
  • You remain responsible for the final medical record and compliance with professional, institutional, reimbursement, and local legal requirements.

4. De-identified content only

The current service is intended only for de-identified clinical content. You must not type, paste, upload, or speak a patient's name, date of birth, medical-record or national identifier, address, email, telephone number, or other information that directly identifies the patient. You must complete the de-identification confirmation truthfully for every text or audio case.

Automated checks are a backstop, not a substitute for your review. They may miss identifiers or identifying combinations. In particular, audio reaches the configured speech-to-text provider before the resulting transcript can be checked and redacted, so direct identifiers must never be spoken. You must also consider whether unusual clinical details could identify a patient in your local context.

5. Accounts and acceptable use

Keep login codes, sessions, and DeskLink access confidential. Do not share an account, bypass access controls, probe the service, upload malicious content, automate excessive requests, infringe third-party rights, or use ScalpelNote unlawfully. Notify us promptly if access may have been compromised or identifiable patient information was submitted.

6. Content and intellectual property

You remain responsible for content you submit and confirm that you may lawfully use it. CoMo Labs and its licensors retain rights in ScalpelNote, its interface, code, scaffold system, and service materials. Subject to these terms, you may use generated drafts for authorised professional documentation. You grant us only the rights needed to host, process, secure, and return content through the service.

7. AI output and availability

AI output can be incomplete, inaccurate, or inappropriate for a particular case or jurisdiction. Review markers reduce risk but do not guarantee correctness. The pilot may contain defects and may be interrupted. Maintain an alternative documentation workflow and do not rely on ScalpelNote for emergency care or time-critical clinical decisions.

8. Privacy and third-party services

Our Privacy Policy explains processing, retention, international transfers, and user rights. The service uses specialist providers, including AI providers, as described there. If your organisation requires a contract, security assessment, data-processing agreement, or prior approval, you must obtain it before use.

9. Liability

To the fullest extent permitted by applicable law, CoMo Labs is not liable for clinical decisions, unreviewed or incorrect drafts, prohibited identifiable content, incorrect user input, unauthorised use, or indirect or consequential loss arising from pilot use. Nothing in these terms excludes liability that cannot lawfully be excluded or limits mandatory consumer, data-protection, or professional rights.

10. Ending access

You may stop using the service, delete reports, and request account erasure. We may suspend access for security, unlawful use, material breach, or risk to patients, users, or the service. Deletion and legally required retention are described in the Privacy Policy.

11. Governing law and global use

These terms are governed by the laws applicable in Abu Dhabi, United Arab Emirates, and disputes are subject to the competent courts of Abu Dhabi. This does not override mandatory rights or jurisdiction rules that apply where you are located. You are responsible for confirming that professional use is permitted in your country and institution. Questions may be sent to info@scalpelnote.ai.